Literature DB >> 28820845

Concomitant Panniculectomy Affects Wound Morbidity but Not Hernia Recurrence Rates in Abdominal Wall Reconstruction: A Propensity Score Analysis.

Salvatore Giordano1, Patrick B Garvey, Donald P Baumann, Jun Liu, Charles E Butler.   

Abstract

BACKGROUND: Studies of abdominal wall reconstruction with concurrent panniculectomy have reported contradictory results. The authors hypothesized that patients undergoing abdominal wall reconstruction with concurrent panniculectomy experience more wound healing complications but similar rates of hernia recurrence compared with abdominal wall reconstruction alone.
METHODS: Of 548 consecutive patients, 305 patients (55.7 percent) underwent abdominal wall reconstruction alone and 243 (44.3 percent) underwent abdominal wall reconstruction with concurrent panniculectomy. Mean follow-up was 30 months. The authors compared these two groups' postoperative complications and outcomes before and after propensity score analysis.
RESULTS: Abdominal wall reconstruction with concurrent panniculectomy patients had a significantly higher overall complication rate (38.3 percent versus 29.2 percent; p = 0.025) and a trend toward a higher surgical-site occurrence rate (27.6 percent versus 20.7 percent; p = 0.06) compared with abdominal wall reconstruction alone. There were significantly higher incidences of skin dehiscence (19.3 percent versus 12.5 percent; p = 0.032), fat necrosis (10.7 percent versus 3.6 percent; p = 0.002), and infection abscess (9.5 percent versus 4.3 percent; p = 0.023) but no significant difference in hernia recurrence (6.9 percent versus 11.5 percent; p = 0.27) at long-term follow-up. Propensity score analysis yielded 188 pairs of matched patients with no significant differences in overall complication and hernia recurrence rates. Significantly higher rates of fat necrosis (9.6 percent versus 4.3 percent; p = 0.041) and abscess (10.1 percent versus 3.2 percent; p = 0.007) were observed in the abdominal wall reconstruction with concurrent panniculectomy group.
CONCLUSIONS: Abdominal wall reconstruction with concurrent panniculectomy is associated with higher wound morbidity but similar surgical-site occurrence and hernia recurrence rates at long-term follow-up. The authors believe that panniculectomy can be safely performed when indicated.

Entities:  

Mesh:

Year:  2017        PMID: 28820845     DOI: 10.1097/PRS.0000000000003855

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  Cutting through the fat: a retrospective analysis of clinical outcomes, cost, and quality of life with the addition of panniculectomy to ventral hernia repair in overweight patients.

Authors:  C E Hutchison; I A Rhemtulla; J T Mauch; R B Broach; F A Enriquez; J A Hernandez; C A Messa; N N Williams; S P Harbison; J P Fischer
Journal:  Hernia       Date:  2019-08-16       Impact factor: 4.739

2.  Comment to: Cutting through the fat: a retrospective analysis of clinical outcomes, cost, and quality of life with the addition of panniculectomy to ventral hernia repair in overweight patients.

Authors:  A F Mericli; C E Butler
Journal:  Hernia       Date:  2020-03-18       Impact factor: 4.739

3.  Diastasis recti and primary midline ventral hernia: the plastic surgery approach.

Authors:  D P Baumann; C E Butler
Journal:  Hernia       Date:  2019-10-10       Impact factor: 4.739

4.  Poly-4-hydroxybutyrate (Phasix™) mesh onlay in complex abdominal wall repair.

Authors:  Adam S Levy; Jaime L Bernstein; Ishani D Premaratne; Christine H Rohde; David M Otterburn; Kerry A Morrison; Michael Lieberman; Alfons Pomp; Jason A Spector
Journal:  Surg Endosc       Date:  2020-05-08       Impact factor: 4.584

5.  Management of ventral hernia in patients with BMI > 30 Kg/m2: outcomes based on an institutional algorithm.

Authors:  S J Baig; P Priya
Journal:  Hernia       Date:  2020-10-12       Impact factor: 4.739

6.  Impact of panniculectomy in complex abdominal wall reconstruction: a propensity matched analysis in 624 patients.

Authors:  Sharbel A Elhage; Matthew N Marturano; Eva B Deerenberg; Jenny M Shao; Tanushree Prasad; Paul D Colavita; Kent W Kercher; B Todd Heniford; Vedra A Augenstein
Journal:  Surg Endosc       Date:  2020-10-20       Impact factor: 4.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.